Rankings
▼
Calendar
PHAT FY 2018 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$831M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$1M
Net Income
-$1M
EPS (Diluted)
$-0.15
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$902,000
Total Liabilities
$2M
Stockholders' Equity
-$1M
Cash & Equivalents
$879,000
← Q1 2018
All Quarters
